CTT PHARMACEUTICAL HOLDINGS, INC. - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 4, 2026
CTT PHARMACEUTICAL HOLDINGS, INC. is a corporate entity tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $23K. Historical track record: 5/5 stars across 13 tracked purchases.
Profile
CTT PHARMACEUTICAL HOLDINGS, INC. is a corporate entity that reports beneficial ownership of shares in CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) under U.S. securities law. It has submitted 13 SEC insider filings since 2024, most recently in November 2025.
| Filer type | Company |
|---|---|
| Role | Director |
| Notability | 20/100 |
Board memberships
- CTT PHARMACEUTICAL HOLDINGS, INC.
Reported roles
- CEO
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★★★ (5/5) |
|---|---|
| Total purchases tracked | 13 |
| Purchases with forward-return data | 13 |
| 30-day win rate | 85% |
| 90-day win rate | 85% |
| Avg 5-day return | +19.12% |
| Avg 30-day return | +22.16% |
| Avg 90-day return | +60.06% |
| Best 30-day return | +51.11% |
Trading Pattern
InsiderAlpha's records for CTT PHARMACEUTICAL HOLDINGS, INC. go back to 2024: 13 primary Form 4 filings, an average of 4.3 per year. The typical open-market purchase is $2K (13 buys totaling $23K). The largest single buy on record is $8K of CTTH in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role CTT PHARMACEUTICAL HOLDINGS, INC. has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Director at CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) - 1 filing, 2025
- CEO at CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) - 12 filings, 2024 to 2025
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-11-24 | CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | P - Open-market purchase | 200.0K | $0.04 | $8K |
| 2025-11-21 | CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | P - Open-market purchase | 62.9K | $0.04 | $3K |
| 2025-10-31 | CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | P - Open-market purchase | 7.0K | $0.06 | $420 |
| 2025-09-23 | CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | P - Open-market purchase | 6.8K | $0.06 | $409 |
| 2025-08-01 | CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | P - Open-market purchase | 44.1K | $0.04 | $2K |
| 2025-08-01 | CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | A - Grant or award | 750.0K | $0.04 | $30K |
| 2025-08-01 | CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | P - Open-market purchase | 15.8K | $0.04 | $553 |
| 2025-07-08 | CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | P - Open-market purchase | 8.0K | $0.03 | $240 |
| 2025-06-24 | CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | P - Open-market purchase | 39.6K | $0.03 | $990 |
| 2025-06-23 | CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | P - Open-market purchase | 16.1K | $0.03 | $402 |
| 2025-06-09 | CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | P - Open-market purchase | 54.8K | $0.03 | $1K |
| 2025-06-09 | CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | A - Grant or award | 150.0K | $0.06 | $9K |
| 2025-06-09 | CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | P - Open-market purchase | 82.2K | $0.05 | $4K |
| 2025-04-10 | CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | P - Open-market purchase | 10.0K | $0.07 | $649 |
| 2024-11-26 | CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | P - Open-market purchase | 23.3K | $0.06 | $1K |
Most Active Insiders Right Now
CTT PHARMACEUTICAL HOLDINGS, INC. has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.
- Magnetar Financial LLC - $8.53B of CRWV open-market activity in the last 90 days
- VisionWave Holdings, Inc. - $7.98B of SVRE open-market activity in the last 90 days
- AI Alpine (Luxembourg) S.a.r.l. - $2.69B of INIO open-market activity in the last 90 days
- SGF FANG Holdings, LP - $2.04B of FANG open-market activity in the last 90 days
- BCP 8 Holdings Mozart Manager L.L.C. - $1.22B of MDLN open-market activity in the last 90 days
- BX Mozart ML-2 Holdco L.P. - $1.22B of MDLN open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Cynosure Group, LLC
- James H. Dahl
- Andrew Dakos
- Joseph Patrick Daly
- Kenneth Bryan Dart
- Charles A. Davis
- Deep Track Biotechnology Master Fund, Ltd.
- Frederick D. Disanto
Frequently Asked Questions
What is CTT PHARMACEUTICAL HOLDINGS, INC.?
CTT PHARMACEUTICAL HOLDINGS, INC. is a corporate entity that reports beneficial ownership of shares in CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) under U.S. securities law. It has submitted 13 SEC insider filings since 2024, most recently in November 2025.…
Has CTT PHARMACEUTICAL HOLDINGS, INC. been buying or selling stock?
Recorded transactions: 13 open-market purchases ($23K) and 0 open-market sales across all tracked filings.
How accurate is CTT PHARMACEUTICAL HOLDINGS, INC.'s historical track record?
Across 13 tracked purchases, CTT PHARMACEUTICAL HOLDINGS, INC. averaged +22.2% avg 30-day return with a 85% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
Where can I see all of CTT PHARMACEUTICAL HOLDINGS, INC.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live CTT PHARMACEUTICAL HOLDINGS, INC. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.